Dr. Arend on the PORTEC-3 Trial for Endometrial Cancer

Gynecologic oncology research at ASCO 2017: Endometrial cancer trialsПодробнее

On the Scene at #SGOMtg: Endometrial Cancer Research HighlightsПодробнее

Dr. Arend Discusses Biomarkers in Endometrial CancerПодробнее

Dr. Levine Discusses a Combination Study in Endometrial CancerПодробнее

Dr. Arend Discusses Targets in Endometrial CancerПодробнее

Dr. Arend on the Rationale of Novel Combinations in Gynecologic CancerПодробнее

Dr. Arend on Personalized Medicine for Endometrial CancerПодробнее

Dr. Leath on Ongoing Trials for Endometrial CancerПодробнее

Dr. Mutch on Biomarkers in Endometrial CancerПодробнее

Dr. Haldorsen Discusses the Challenges With Imaging in Endometrial CancerПодробнее

Precision oncology in endometrial cancerПодробнее

Dr. Backes on the FILM Trial in Endometrial CancerПодробнее

Dr. Glaspy on Immunotherapy in Endometrial CancerПодробнее

Dr. Oaknin on the GARNET Study in Endometrial CancerПодробнее

Dr. Taylor on the Current Treatment Landscape for Endometrial CancerПодробнее

Monitoring for an Endometrial Cancer RecurrenceПодробнее

Research priorities for metastatic endometrial cancerПодробнее

Dr. Makker on Unmet Needs for Patients with Advanced Endometrial CancerПодробнее

Dr. Matulonis Discusses QoL Data from GOG-258 in Endometrial CancerПодробнее